Navigation Links
Steps Toward Stopping Autoimmune Disease: International Consortium Identifies Genes Linked to Lupus
Date:1/20/2008

NEW YORK, Jan. 20 /PRNewswire-USNewswire/ -- A landmark genetic study has identified multiple genes linked to systemic lupus erythematosus (SLE), or lupus, a debilitating autoimmune disease that affects an estimated 1.4 million Americans.

Lupus can affect the joints, kidneys, heart, lungs, brain and blood and occurs in about 31 out of every 100,000 people. Women are nine times more likely than men to develop the condition, which is often difficult to diagnose.

In 2005 the Alliance for Lupus Research (ALR) formed and supported the International Systemic Lupus Erythematosus Genetics (SLEGEN) Consortium, charging scientists with searching for genetic variants that might predispose an individual to developing lupus.

Published in the January 20, 2008, issue of Nature Genetics, initial study results uncovered several genes linked to lupus and underscore the importance of genetic variants in diseases that affect immune function. The findings will ultimately lead to new therapies and earlier diagnosis.

"The SLEGEN study is a model for collaborative genetic research," said Mary Kuntz Crow, M.D., an immunity and inflammation specialist at the Hospital for Special Surgery in New York and 2008 chair of the ALR Scientific Advisory Board. "The ALR approach of supporting investigations targeted toward developing new therapies for people with lupus is unique and meaningful."

Project co-Director Carl Langefeld, Ph.D., added, "These results suggest biologic pathways that help us understand the condition better and suggest additional genetic and non-genetic triggers. In addition, they will help delineate the genetic distinctions between rheumatoid arthritis, lupus and other autoimmune diseases, which could lead to earlier, more accurate diagnoses."

Langefeld, who is director of the Center for Public Health Genomics at Wake Forest University in Winston-Salem, N.C., also noted how satisfying the study results were. "This is one of those t
'/>"/>

SOURCE Alliance for Lupus Research
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development
2. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
3. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
4. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
5. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
6. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
7. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
8. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
9. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
10. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
11. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...erland,Nov.25/PRNewswire/-- FromNovember16-18,Phon...ons,presentedthesecondeditionoftheHearingCareforAd...population.Theconferencebroughttogetherleadingexpe...n250clinicianswhoworkeverydaywitholderpeoplewithhe...ussthelatestresearchandtrendsinhearingcareforolder...
(Date:11/25/2009)...v.25/PRNewswire-FirstCall/--Formanyofthemillionsof...ingwithuntreated hearingloss ,theholidaysmaynotbea...yer,seniorvicepresidentofHearUSA(Amex: EAR ),oneof...es,saidstudieshavelinkedhearinglosstostress,frustr...iedatholidaygatheringswithfamiliesandfriends,whenm...
(Date:11/25/2009)....25/PRNewswire/--RegadoBiosciences,aprivatelyheldc...swithactivecontrolagents,announcedthatDavidMazzo,P...ay21stAnnualHealthCareConferenceattheNewYorkPalace...enat1:10pm(EST)onTuesday,December1andwillincludean...ddevelopmentprogram,theanticoagulantsystem,REG1.Th...
Breaking Medicine Technology:Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Outsourcing of IT Requirements by Healthcare Organisations Promotes All Round Benefits Says Frost 26 Sullivan 53729 1Outsourcing of IT Requirements by Healthcare Organisations Promotes All Round Benefits Says Frost 26 Sullivan 53729 2Outsourcing of IT Requirements by Healthcare Organisations Promotes All Round Benefits Says Frost 26 Sullivan 53729 3Outsourcing of IT Requirements by Healthcare Organisations Promotes All Round Benefits Says Frost 26 Sullivan 53729 4Londons Barts Hospital Selects Varian Equipment to Offer Advanced Radiotherapy to More Cancer Patients 53726 1Londons Barts Hospital Selects Varian Equipment to Offer Advanced Radiotherapy to More Cancer Patients 53726 2Londons Barts Hospital Selects Varian Equipment to Offer Advanced Radiotherapy to More Cancer Patients 53726 3Novo Nordisk Appoints Per Falk M D Ph D as Vice President for Clinical Medical and Regulatory Affairs for North America 53723 1Novo Nordisk Appoints Per Falk M D Ph D as Vice President for Clinical Medical and Regulatory Affairs for North America 53723 2
...AN FRANCISCO & NEW DELHI, India--(BUSINESS WIR...th, a US-based non-profit,pharmaceutical company, ...ts first approved drug product, Paromomycin IM,Inj... issue of The,New England Journal of Medicine (NEJ...romomycin is safe, effective, and well suited,to c...
...roadest, Most Comprehensive Survey Provides New Be...ON, June 21, 2007 /PRNewswire-USNewswire/ -- The,f..., -- First nationwide study of the prevalence ...reus (MRSA), a virulent multi-drug resistant organ...-- MRSA prevalence study findings significantly ex...
Other Medicine Technology:Research on New Treatment for Neglected Disease Published in The,New England Journal of Medicine 2Research on New Treatment for Neglected Disease Published in The,New England Journal of Medicine 3Research on New Treatment for Neglected Disease Published in The,New England Journal of Medicine 4Nationwide MRSA Prevalence Study to Demonstrate Full Scope of,'Superbug' Threat Facing U.S. Healthcare Facilities and Patients 2
(Date:11/26/2009)...ations announces a highly effective and unconventi...ng to make an economic recovery. , ...s the type of challenge that could send ailing hol... David Benton, business growth expert and author o...; The Rfactor Intensive . “Fear is one of...
(Date:11/25/2009)...re-FirstCall/-- OnyxPharmaceuticals,Inc.(Nasdaq: ...toreventsinDecember: ,, ASHBriefing ,, ...ncipalinvestigatorswilldiscussdatapresentationssur...plemyeloma,asfeaturedatthe51stAmericanSocietyofHem...,LA.Theteleconferencewillbeginat9:00a.m.CT/10:00a....
(Date:11/25/2009)...e-USNewswire/--AnarticlebyJanetWoodcock,M.D.,direc...tled"ADifficultBalance-PainManagement,DrugSafety,a...andJournalofMedicine. ,, (Logo: http://www.news...earticle,WoodcockdiscussesFDAeffortstostrikeabalan...dmanagingtherisksposedbyvariousanalgesics.Asexampl...
(Date:11/25/2009)...r who were treated with cisplatin-based chemothera...gical side effects and Raynaud-like phenomena, tha...rding to a new study published online November 25 ... , Marianne Brydy, M.D., of the Department of On...Norway, and colleagues conducted a cross-sectional...
(Date:11/25/2009)...to draw definite conclusions, experts say, , ...diabetic patients with blocked coronary arteries, ...ne year whether patients undergo bypass surgery or...port. , Bypass surgery has been the standard tr... disease. However, less invasive approaches such a...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3
... has raised questions about plans recently announc...to launch a campaign// promoting male circumcision... Organization and UNAIDS as a way to help reduce t...ot decided if it will pursue the campaign. UNAIDS ...
...g in the happiness of her 27th marriage anniversar...en she began to suffer// hot flashes, she dismisse...y Mandy was pregnant, but didn’t think so even in ...ing lunch, Mandy experienced a chilling pain in th...
...ws with one more ailment added to its list of expl... enhanced risk of colon cancer. // Scientist...e unearthed the link between obesity and cancer of... cells grow in the colon, rectum and appendix of s...
...) is urgently reminding the public that contact wi...infants//, small children, and adults with impaire...almonella, a group of bacteria that can cause seve...et turtle in the home. Salmonella is the ge...
... claims to be the world's oldest inhabited city. I... Its population of 1.74 millions is said to be ...ry where water is a scarce commodity, whatever wat... shrub whose leaves, when you chew them, can induc...
...isk of developing colon cancer, the third most com...cells in the body of obese people produce leptin -...er. The more fat cells a person has, the more lept... in the colon, rectum and appendix. Research...
Other Medicine News:Health News:NYC Mayor Raises Questions About Male Circumcision as HIV Prevention Method 2Health News:FDA Re-Emphasizes Warnings to Consumers on Risks of Pet Turtles 2Health News:Drug Uses Up Water in Yemeni Capital, People Must Relocate 2
Visions PV 018
Shimadzu SDU-2200
Aplio
Atlantis SR Plus Catheter
Medicine Products: